Developer docs
API playgroundTry for free, no card

Search company profiles

RBC Medical Innovations

Full company profile

uuid000bop1

Namestring
RBC Medical Innovations
Legal namestring
Vantage MedTech
Websiteurl
rbccorp.com
Company typeenum
Private
Founded yearint
1994
Descriptiontext

RBC Medical Innovations is a private U.S. medical device company founded in 1994 and headquartered in Lenexa, Kansas, operating what appears to be the Vantage MedTech brand (vantagedmedtech.com). The company is a contract development and manufacturing organization (CDMO) focused on complex electromechanical medical devices, with stated capabilities spanning regulatory strategy, product development, new product introduction, and contract manufacturing. It reports a track record of 30+ years of experience, 150+ specialized medical device engineers, and 1,600+ devices successfully developed with a 98% on-time delivery rate.

The company's core technology offering is the Advantage Platforms® suite — a set of pre-validated, modular reference architectures covering pulsed field ablation (AdvantagePFA™), radiofrequency ablation (AdvantageRF™), microwave ablation, irreversible electroporation, gas and fluid management (AdvantageGFM™), user interface (AdvantageUI™), and peristaltic-pump fluid delivery. These platforms are complemented by service capabilities in advanced visualization, complex electromechanical systems, connected devices, energy delivery, drug delivery/infusion, VAD/artificial heart, and medical device software. The company operates a dual-site footprint with a Northeast Design Center in Lyndhurst, NJ and a Midwest Design and Manufacturing Center in Olathe, KS.

The business model combines three revenue streams: (1) contract development services billed on a project basis, covering regulatory affairs, quality assurance, industrial design, and cybersecurity; (2) contract manufacturing services for medical device production; and (3) platform licensing of the Advantage Platforms® suite, including a generator lease program. The go-to-market is direct enterprise sales targeting medical device companies ranging from early-stage startups (e.g., REACT Holdings) to large enterprises (e.g., Bracco Diagnostics, Katalyst Surgical), with no public pricing or subscription model. The company is privately held with no disclosed institutional investors, parent company, or funding rounds.

Short descriptiontext

RBC Medical Innovations, operating as Vantage MedTech, is a U.S. medical device contract development and manufacturing organization serving medical device firms from startups to enterprises, with pre-validated Advantage Platforms® and end-to-end capabilities from regulatory strategy through manufacturing.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersLenexa, United States
HQ citystring
Lenexa
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical device development, contract manufacturing services, FDA regulatory affairs, electromechanical device design, medical device engineering
NAICS code1 code
  • Surgical and Medical Instrument Manufacturing339112
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Medical Device Contract Development and Manufacturing
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Contract Development Services
TypeProfessional Services
Description

Full-service medical device product development including strategy, feasibility, regulatory affairs, quality assurance, industrial design, and cybersecurity. Revenue is generated through project-based professional services engagements.

vantagemedtech.com
2Contract Manufacturing Services
TypeHardware Sales
Description

End-to-end manufacturing capabilities for medical devices including new product introduction and transition from design to production. Revenue generated through manufacturing services.

vantagemedtech.com
3Platform Licensing
TypeLicensing Royalties
Description

Pre-developed platform architectures (Advantage Platforms®) available for licensing to accelerate customer product development, including generator lease options.

vantagemedtech.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 5 records shown
1Advantage Platforms®
Description

Pre-built reference architectures for accelerated product development including AdvantagePFA™ (Pulsed Field Ablation), AdvantageRF™ (Radiofrequency Ablation), AdvantageGFM™ (Gas and Fluid Management), AdvantageUI™ (User Interface platforms), and AdvantageMW™ (Microwave Ablation)

vantagemedtech.com
+4 more records
Core offering1 text field

RBC Medical Innovations (operating as Vantage MedTech) is a contract development and manufacturing organization (CDMO) for complex electromechanical medical devices. The company provides end-to-end services spanning regulatory strategy and feasibility, product design and engineering, new product introduction, and full-scale manufacturing. Its offering is anchored by the proprietary Advantage Platforms® suite of pre-validated technology foundations for ablation, gas and fluid management, and user interface applications, which customers can license to accelerate development.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • 98% on-time delivery rate
+1 more record
Product overview1 text field

Vantage MedTech offers a unified contract development and manufacturing platform for complex electromechanical medical devices. The portfolio centers on Advantage Platforms®, a suite of pre-validated technology foundations including AdvantagePFA™ (Pulsed Field Ablation), AdvantageRF™ (Radiofrequency Ablation), AdvantageGFM™ (Gas and Fluid Management), and AdvantageUI™ (User Interface), complemented by specialized platforms for Irreversible Electroporation, Microwave Ablation, and Fluid Delivery. Supporting these platforms are integrated services spanning Strategy & Feasibility, Product Development (with embedded capabilities in cybersecurity, industrial design, regulatory affairs, and quality assurance), New Product Introduction, and Contract Manufacturing. The company also provides targeted expertise in Advanced Visualization, Complex Electromechanical systems, Connected Devices, Energy Delivery, and Medical Software development.

Product and service13 records
1Advantage Platforms®
CategoryPre-validated Technology Platforms
Description

A suite of pre-validated, modular technology platform architectures enabling accelerated medical device development across multiple therapeutic segments, including RF ablation, pulsed field ablation, irreversible electroporation, microwave ablation, fluid management, and generator systems. Licensed to medical device companies.

2AdvantagePFA™ (Pulsed Field Ablation)
CategoryPre-validated Technology Platforms
Description

Pre-validated pulsed field ablation platform for cardiac ablation procedures, available for licensing to medical device developers.

3AdvantageRF™ (Radiofrequency Ablation)
CategoryPre-validated Technology Platforms
Description

Pre-validated radiofrequency ablation platform for therapeutic applications, available for licensing to medical device developers.

4AdvantageGFM™ (Gas and Fluid Management)
CategoryPre-validated Technology Platforms
Description

Pre-validated gas and fluid management platform for medical device applications, available for licensing to medical device developers.

5AdvantageUI™ (User Interface)
CategoryPre-validated Technology Platforms
Description

User interface platform for medical device control and visualization, available for licensing to medical device developers.

6Irreversible Electroporation Platform
CategoryPre-validated Technology Platforms
Description

Pre-validated platform technology for irreversible electroporation ablation procedures, available for licensing to medical device developers.

7Microwave Ablation Platform
CategoryPre-validated Technology Platforms
Description

Pre-validated platform technology for microwave ablation applications, available for licensing to medical device developers.

8Fluid Delivery Platform
CategoryPre-validated Technology Platforms
Description

Pre-validated peristaltic pump-based fluid delivery platform for ablation procedures, available for licensing to medical device developers.

9Generator Lease Program
CategoryEquipment Leasing
Description

Equipment lease program for generators used in conjunction with the company's ablation platforms.

10Medical Device Product Development Services
CategoryContract Development Services
Description

End-to-end product development services for medical devices, encompassing strategy and feasibility, electrical and software design, cybersecurity, industrial design, regulatory affairs, and quality assurance. Served to medical device companies from early-stage startups through established firms.

11New Product Introduction (NPI) Services
CategoryContract Development Services
Description

Services guiding medical device products through design transfer and the transition from design to manufacturing launch.

12Medical Device Contract Manufacturing
CategoryContract Manufacturing Services
Description

End-to-end manufacturing services for medical devices, including electromechanical, connected, and energy-delivery systems, with capabilities for new product introduction and transition from design to production.

13DHF Remediation Services
CategoryRegulatory and Quality Services
Description

Design History File (DHF) remediation and documentation services to bring medical device products into compliance with regulatory requirements.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Flex Medical Solutions is a global contract manufacturer with medical device design, manufacturing, and supply chain services. Broad incumbent with similar CDMO model but significantly larger scale and broader capabilities.

TypeDirect peer
Description

Life Science Outsourcing provides contract manufacturing and assembly services for medical devices. Direct peer in the medical device CDMO space serving OEMs with similar product development and manufacturing capabilities.

TypeEmerging player
Description

Triple Ring Technologies provides medical device product development, engineering services, and regulatory consulting. Comparable given overlapping R&D, design, and regulatory service capabilities targeting complex medical devices.

TypeDirect peer
Description

Paragon Medical (part of MW Industries) is a medical device contract manufacturer specializing in implants, instruments, and complex assemblies. Direct peer with overlapping complex medical device manufacturing capabilities.

TypeDirect peer
Description

Tegra Medical is a precision medical device contract manufacturer specializing in complex devices and implants. Directly comparable given shared focus on complex electromechanical medical devices and contract manufacturing services.

TypeDirect peer
Description

Vesta is a medical device contract manufacturer offering precision molding, assembly, and finished device manufacturing. Direct peer with comparable medical device CDMO service model and customer base.

TypeDirect peer
Description

Integer Holdings is one of the largest medical device outsource manufacturers, offering contract development, manufacturing, and finishing for medical devices and components. Direct comparable given overlapping CDMO capabilities and complex device focus.

TypeDirect peer
Description

Donatelle Plastics is a medical device contract manufacturer with capabilities in molding, assembly, and finished device production. Comparable as a US-based mid-market medical device CDMO serving complex device OEMs.

TypeDirect peer
Description

Spectrum Plastics Group provides medical device contract manufacturing with capabilities in extrusion, injection molding, and finished device assembly. Direct peer in medical device CDMO services with similar end-market focus.

TypeDirect peer
Description

Nordson Medical (formerly Vention Medical) provides medical device component and contract manufacturing services, including design, prototyping, and production. Direct peer with similar end-to-end medical device CDMO capabilities.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

RBC Medical Innovations

Medical Device Contract Development and Manufacturingrbccorp.com

RBC Medical Innovations, operating as Vantage MedTech, is a U.S. medical device contract development and manufacturing organization serving medical device firms from startups to enterprises, with pre-validated Advantage Platforms® and end-to-end capabilities from regulatory strategy through manufacturing.

What RBC Medical Innovations does

RBC Medical Innovations is a private U.S. medical device company founded in 1994 and headquartered in Lenexa, Kansas, operating what appears to be the Vantage MedTech brand (vantagedmedtech.com). The company is a contract development and manufacturing organization (CDMO) focused on complex electromechanical medical devices, with stated capabilities spanning regulatory strategy, product development, new product introduction, and contract manufacturing. It reports a track record of 30+ years of experience, 150+ specialized medical device engineers, and 1,600+ devices successfully developed with a 98% on-time delivery rate.

The company's core technology offering is the Advantage Platforms® suite — a set of pre-validated, modular reference architectures covering pulsed field ablation (AdvantagePFA™), radiofrequency ablation (AdvantageRF™), microwave ablation, irreversible electroporation, gas and fluid management (AdvantageGFM™), user interface (AdvantageUI™), and peristaltic-pump fluid delivery. These platforms are complemented by service capabilities in advanced visualization, complex electromechanical systems, connected devices, energy delivery, drug delivery/infusion, VAD/artificial heart, and medical device software. The company operates a dual-site footprint with a Northeast Design Center in Lyndhurst, NJ and a Midwest Design and Manufacturing Center in Olathe, KS.

The business model combines three revenue streams: (1) contract development services billed on a project basis, covering regulatory affairs, quality assurance, industrial design, and cybersecurity; (2) contract manufacturing services for medical device production; and (3) platform licensing of the Advantage Platforms® suite, including a generator lease program. The go-to-market is direct enterprise sales targeting medical device companies ranging from early-stage startups (e.g., REACT Holdings) to large enterprises (e.g., Bracco Diagnostics, Katalyst Surgical), with no public pricing or subscription model. The company is privately held with no disclosed institutional investors, parent company, or funding rounds.

RBC Medical Innovations firmographics

Firmographics
Name
RBC Medical Innovations
Legal name
Vantage MedTech
Website
https://rbccorp.com
Company type
Private
Founded year
1994
Operating status
Operating
Headcount range
51–100 employees
Short description
RBC Medical Innovations, operating as Vantage MedTech, is a U.S. medical device contract development and manufacturing organization serving medical device firms from startups to enterprises, with pre-validated Advantage Platforms® and end-to-end capabilities from regulatory strategy through manufacturing.
Ownership category
akta.pro rank

Where RBC Medical Innovations is headquartered

Location

Headquarters

HQ city
Lenexa
HQ country
United States
HQ region
North America

Offices2 records

Markets served

RBC Medical Innovations business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales

Revenue model

  1. Contract Development Services: Full-service medical device product development including strategy, feasibility, regulatory affairs, quality assurance, industrial design, and cybersecurity. Revenue is generated through project-based professional services engagements.
  2. Contract Manufacturing Services: End-to-end manufacturing capabilities for medical devices including new product introduction and transition from design to production. Revenue generated through manufacturing services.
  3. Platform Licensing: Pre-developed platform architectures (Advantage Platforms®) available for licensing to accelerate customer product development, including generator lease options.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

RBC Medical Innovations product offering

Product offering

Core offering

RBC Medical Innovations (operating as Vantage MedTech) is a contract development and manufacturing organization (CDMO) for complex electromechanical medical devices. The company provides end-to-end services spanning regulatory strategy and feasibility, product design and engineering, new product introduction, and full-scale manufacturing. Its offering is anchored by the proprietary Advantage Platforms® suite of pre-validated technology foundations for ablation, gas and fluid management, and user interface applications, which customers can license to accelerate development.

Product overview

Vantage MedTech offers a unified contract development and manufacturing platform for complex electromechanical medical devices. The portfolio centers on Advantage Platforms®, a suite of pre-validated technology foundations including AdvantagePFA™ (Pulsed Field Ablation), AdvantageRF™ (Radiofrequency Ablation), AdvantageGFM™ (Gas and Fluid Management), and AdvantageUI™ (User Interface), complemented by specialized platforms for Irreversible Electroporation, Microwave Ablation, and Fluid Delivery. Supporting these platforms are integrated services spanning Strategy & Feasibility, Product Development (with embedded capabilities in cybersecurity, industrial design, regulatory affairs, and quality assurance), New Product Introduction, and Contract Manufacturing. The company also provides targeted expertise in Advanced Visualization, Complex Electromechanical systems, Connected Devices, Energy Delivery, and Medical Software development.

Differentiator

Problem solved

Functional benefit

Brands

  • Advantage Platforms®: Pre-built reference architectures for accelerated product development including AdvantagePFA™ (Pulsed Field Ablation), AdvantageRF™ (Radiofrequency Ablation), AdvantageGFM™ (Gas and Fluid Management), AdvantageUI™ (User Interface platforms), and AdvantageMW™ (Microwave Ablation)
  • AdvantagePFA™
  • AdvantageRF™
  • AdvantageGFM™
  • AdvantageUI™

Products and services

  • Advantage Platforms® A suite of pre-validated, modular technology platform architectures enabling accelerated medical device development across multiple therapeutic segments, including RF ablation, pulsed field ablation, irreversible electroporation, microwave ablation, fluid management, and generator systems. Licensed to medical device companies.
  • AdvantagePFA™ (Pulsed Field Ablation) Pre-validated pulsed field ablation platform for cardiac ablation procedures, available for licensing to medical device developers.
  • AdvantageRF™ (Radiofrequency Ablation) Pre-validated radiofrequency ablation platform for therapeutic applications, available for licensing to medical device developers.
  • AdvantageGFM™ (Gas and Fluid Management) Pre-validated gas and fluid management platform for medical device applications, available for licensing to medical device developers.
  • AdvantageUI™ (User Interface) User interface platform for medical device control and visualization, available for licensing to medical device developers.
  • Irreversible Electroporation Platform Pre-validated platform technology for irreversible electroporation ablation procedures, available for licensing to medical device developers.
  • Microwave Ablation Platform Pre-validated platform technology for microwave ablation applications, available for licensing to medical device developers.
  • Fluid Delivery Platform Pre-validated peristaltic pump-based fluid delivery platform for ablation procedures, available for licensing to medical device developers.
  • Generator Lease Program Equipment lease program for generators used in conjunction with the company's ablation platforms.
  • Medical Device Product Development Services End-to-end product development services for medical devices, encompassing strategy and feasibility, electrical and software design, cybersecurity, industrial design, regulatory affairs, and quality assurance. Served to medical device companies from early-stage startups through established firms.
  • New Product Introduction (NPI) Services Services guiding medical device products through design transfer and the transition from design to manufacturing launch.
  • Medical Device Contract Manufacturing End-to-end manufacturing services for medical devices, including electromechanical, connected, and energy-delivery systems, with capabilities for new product introduction and transition from design to production.
  • DHF Remediation Services Design History File (DHF) remediation and documentation services to bring medical device products into compliance with regulatory requirements.

Quantifiable outcome

  • 98% on-time delivery rate
  • +1 more outcomes

Companies that use RBC Medical Innovations

Customer profile

Named customers4 records

Segments1 record

Ideal customer profiles1 record

RBC Medical Innovations technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

RBC Medical Innovations partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

RBC Medical Innovations competitors and assessment

Company assessment

Broad incumbents

  • Flex Medical Solutions: Flex Medical Solutions is a global contract manufacturer with medical device design, manufacturing, and supply chain services. Broad incumbent with similar CDMO model but significantly larger scale and broader capabilities.

Direct peers

  • Life Science Outsourcing: Life Science Outsourcing provides contract manufacturing and assembly services for medical devices. Direct peer in the medical device CDMO space serving OEMs with similar product development and manufacturing capabilities.
  • Paragon Medical: Paragon Medical (part of MW Industries) is a medical device contract manufacturer specializing in implants, instruments, and complex assemblies. Direct peer with overlapping complex medical device manufacturing capabilities.
  • Tegra Medical: Tegra Medical is a precision medical device contract manufacturer specializing in complex devices and implants. Directly comparable given shared focus on complex electromechanical medical devices and contract manufacturing services.
  • Vesta (formerly MedPlast): Vesta is a medical device contract manufacturer offering precision molding, assembly, and finished device manufacturing. Direct peer with comparable medical device CDMO service model and customer base.
  • Integer Holdings Corporation: Integer Holdings is one of the largest medical device outsource manufacturers, offering contract development, manufacturing, and finishing for medical devices and components. Direct comparable given overlapping CDMO capabilities and complex device focus.
  • Donatelle Plastics: Donatelle Plastics is a medical device contract manufacturer with capabilities in molding, assembly, and finished device production. Comparable as a US-based mid-market medical device CDMO serving complex device OEMs.
  • Spectrum Plastics Group: Spectrum Plastics Group provides medical device contract manufacturing with capabilities in extrusion, injection molding, and finished device assembly. Direct peer in medical device CDMO services with similar end-market focus.
  • Nordson Medical: Nordson Medical (formerly Vention Medical) provides medical device component and contract manufacturing services, including design, prototyping, and production. Direct peer with similar end-to-end medical device CDMO capabilities.

Emerging players

  • Triple Ring Technologies: Triple Ring Technologies provides medical device product development, engineering services, and regulatory consulting. Comparable given overlapping R&D, design, and regulatory service capabilities targeting complex medical devices.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

RBC Medical Innovations social profiles

Digital presence

RBC Medical Innovations financial estimates

Financial estimate

Revenue estimate

Valuation estimate

RBC Medical Innovations leadership team

Management profile

Number of profiles

Profiles3 records

RBC Medical Innovations funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

RBC Medical Innovations M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about RBC Medical Innovations

What does RBC Medical Innovations do?

RBC Medical Innovations (operating as Vantage MedTech) is a contract development and manufacturing organization (CDMO) for complex electromechanical medical devices. The company provides end-to-end services spanning regulatory strategy and feasibility, product design and engineering, new product introduction, and full-scale manufacturing. Its offering is anchored by the proprietary Advantage Platforms® suite of pre-validated technology foundations for ablation, gas and fluid management, and user interface applications, which customers can license to accelerate development.

Is RBC Medical Innovations a public or private company?

RBC Medical Innovations is a private company. It is classified as unknown and is currently operating.

When was RBC Medical Innovations founded?

RBC Medical Innovations was founded in 1994. It employs 51 to 100 people.

Where is RBC Medical Innovations based?

RBC Medical Innovations is headquartered in Lenexa, United States, in the North America region.

How does RBC Medical Innovations make money?

Three revenue lines are on record. Contract Development Services are the primary driver. The others are contract Manufacturing Services and platform Licensing.

Who are RBC Medical Innovations's main competitors?

Flex Medical Solutions is listed as a broad incumbent. Direct peers are Life Science Outsourcing, Paragon Medical, Tegra Medical, Vesta (formerly MedPlast), Integer Holdings Corporation, Donatelle Plastics, Spectrum Plastics Group and Nordson Medical. Triple Ring Technologies is listed as an emerging player.

Does RBC Medical Innovations have an API?

No public API is recorded for RBC Medical Innovations.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireAmpersand Portfolio Company Sterling Medical Devices Recapitalizes RBC Medical Innovations, Merges EntitiesSterling Medical Devices has completed a recapitalization and merger with RBC Medical Innovations, creating a combined entity with expanded design, development, and manufacturing capabilities for electromechanical medical devices. As part of the transaction, industry veteran David Montecalvo was appointed CEO of the new combined company, effective immediately. The move is intended to accelerate customer-focused innovation by integrating Sterling's regulatory expertise with RBC's energy-based device capabilities.PR NewswireNeuroOne® Issues Letter to Stockholders in Connection With 2022 Annual Meeting of StockholdersNeuroOne Medical Technologies Corporation published its 2022 Annual Letter to Stockholders recapping fiscal year 2021 achievements and outlining milestones for fiscal year 2022, with key highlights including a $12.5 million equity raise in January 2021 and Nasdaq uplisting in May 2021. The company is developing its Evo thin film electrode platform technology for treating epilepsy, chronic back pain, and Parkinson's disease, with an expected FDA re-submission for its sEEG product line in August 2022 and ongoing partnerships with RBC Medical for ablation electrode hardware and Zimmer Biomet for commercialization support. The letter emphasizes positive physician and patient feedback while highlighting upcoming development goals including completion of the ablation system, chronic stimulation electrode development, and expansion of new indications.PR NewswireNeuroOne Reports Fourth Fiscal Quarter and Full Fiscal Year 2021 Financial Results and Provides Corporate UpdateNeuroOne Medical Technologies reported Q4 and full fiscal year 2021 financial results, achieving $178,000 in product revenue for the year with a net loss of $9.9 million, compared to a net loss of $13.6 million in fiscal 2020. The company received FDA 510(k) clearance for its second diagnostic product (Evo sEEG Electrode), secured initial stocking orders from Zimmer Biomet, executed an agreement with RBC Medical Innovations for RF generator development, and completed an animal feasibility study for its combination recording and ablation technology. Subsequent to fiscal year end, NeuroOne closed a $13.35 million public offering to fund commercialization of its diagnostic line and development of its first therapeutic ablation electrode.PR NewswireGrowth Through Partnership- KoKo, LLC & RBC Medical InnovationsKoKo, LLC announced a partnership with RBC Medical Innovations to expand manufacturing of respiratory diagnostic equipment, including spirometers and plethysmographs. The collaboration aims to stabilize KoKo's supply chain to meet growing demand in the pulmonary function testing market, which is forecast to grow at a 10% CAGR for spirometry and 4% for PFT through 2025. Both companies, headquartered in the United States (Colorado and Kansas respectively), will focus on innovation and research and development to enhance patient care.